This approach will provide a useful tool to facilitate the study of tau aggregation in the absence of any overexpression of the protein, post-translational modification, or inducers of assembly and ultimately to study the mechanism of action of tau aggregation inhibitors that target tau seeding and neuronal transmission in AD and related tauopathies. The gene discussed is MAPT; the disease is Alzheimer disease.